| Stem definition | Drug id | CAS RN |
|---|---|---|
| 1364 | 70-30-4 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| April 19, 1949 | FDA | SANOFI AVENTIS US |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | D08AE01 | DERMATOLOGICALS ANTISEPTICS AND DISINFECTANTS ANTISEPTICS AND DISINFECTANTS Phenol and derivatives |
| FDA EPC | N0000175486 | Antiseptic |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000891 | Anti-Infective Agents, Local |
| CHEBI has role | CHEBI:22153 | acaricides |
| CHEBI has role | CHEBI:33282 | bactericides |
| CHEBI has role | CHEBI:48218 | antiseptics |
| CHEBI has role | CHEBI:86328 | anti-fungal agrichemical |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Burn injury | contraindication | 48333001 | |
| Breastfeeding (mother) | contraindication | 413712001 | |
| Denuded skin | contraindication | 418242004 | |
| CNS Toxicity | contraindication |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 6.2 | acidic |
| pKa2 | 8.97 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Prostaglandin G/H synthase 2 | Enzyme | IC50 | 6.19 | DRUG MATRIX | |||||
| Adenosine receptor A2a | GPCR | Ki | 6.04 | DRUG MATRIX | |||||
| Alpha-2A adrenergic receptor | GPCR | Ki | 5.69 | DRUG MATRIX | |||||
| Sodium-dependent serotonin transporter | Transporter | Ki | 5.64 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2B | GPCR | Ki | 5.44 | DRUG MATRIX | |||||
| 5-hydroxytryptamine receptor 2C | GPCR | Ki | 5.62 | DRUG MATRIX | |||||
| Alpha-2C adrenergic receptor | GPCR | Ki | 5.99 | DRUG MATRIX | |||||
| Adenosine receptor A3 | GPCR | Ki | 6.44 | DRUG MATRIX | |||||
| Estrogen receptor | Nuclear hormone receptor | IC50 | 5.67 | CHEMBL | |||||
| Estrogen receptor beta | Nuclear hormone receptor | IC50 | 7.01 | CHEMBL | |||||
| Cytochrome P450 1A2 | Enzyme | IC50 | 5.88 | DRUG MATRIX | |||||
| Epidermal growth factor receptor | Kinase | IC50 | 6.13 | DRUG MATRIX | |||||
| Cytochrome P450 2C19 | Enzyme | IC50 | 5.91 | DRUG MATRIX | |||||
| Tyrosine-protein kinase Lck | Kinase | IC50 | 5.61 | DRUG MATRIX | |||||
| Tyrosine-protein kinase Fyn | Kinase | IC50 | 5.46 | DRUG MATRIX | |||||
| Receptor tyrosine-protein kinase erbB-2 | Kinase | IC50 | 5.48 | DRUG MATRIX | |||||
| Thromboxane-A synthase | Enzyme | IC50 | 5.51 | DRUG MATRIX | |||||
| Mitogen-activated protein kinase 3 | Kinase | IC50 | 5.61 | DRUG MATRIX | |||||
| Mitogen-activated protein kinase 14 | Kinase | IC50 | 7.06 | DRUG MATRIX | |||||
| Substance-K receptor | GPCR | Ki | 5.86 | DRUG MATRIX | |||||
| Mitogen-activated protein kinase 1 | Kinase | IC50 | 6.71 | DRUG MATRIX | |||||
| Transitional endoplasmic reticulum ATPase | Enzyme | IC50 | 5.26 | CHEMBL | |||||
| Heat shock cognate 71 kDa protein | Unclassified | IC50 | 4.56 | CHEMBL | |||||
| Heat shock 70 kDa protein 1A | Unclassified | IC50 | 4.72 | CHEMBL | |||||
| Macrophage migration inhibitory factor | Unclassified | Ki | 5.26 | CHEMBL | |||||
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | Unclassified | INHIBITOR | IC50 | 5.01 | IUPHAR | ||||
| 78 kDa glucose-regulated protein | Unclassified | IC50 | 5.04 | CHEMBL | |||||
| Acetylcholinesterase | Enzyme | IC50 | 5.52 | DRUG MATRIX | |||||
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Enzyme | INHIBITOR | CHEMBL | CHEMBL | |||||
| Sodium/potassium-transporting ATPase subunit alpha-2 | Ion channel | IC50 | 5.21 | DRUG MATRIX | |||||
| D-lactate dehydrogenase | Enzyme | WOMBAT-PK | |||||||
| Androgen receptor | Transcription factor | Ki | 5.48 | DRUG MATRIX | |||||
| Zinc finger protein mex-5 | Cytosolic other | EC50 | 4.72 | CHEMBL | |||||
| M1-family alanyl aminopeptidase | Enzyme | IC50 | 4.24 | CHEMBL | |||||
| Cytoplasmic zinc-finger protein | Unclassified | EC50 | 4.34 | CHEMBL | |||||
| Envelope glycoprotein gp160 | Viral envelope protein | IC50 | 5.14 | CHEMBL | |||||
| Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | Unclassified | IC50 | 5.14 | CHEMBL | |||||
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D, N-acyl phosphatidylethanolamine phospholipase D, NAPE-PLD, NAPE-hydrolyzing phospholipase D, EC 3.1.4.54 | Unclassified | IC50 | 4.96 | CHEMBL |
| ID | Source |
|---|---|
| 4018252 | VUID |
| N0000146582 | NUI |
| D00859 | KEGG_DRUG |
| 4018252 | VANDF |
| C0019435 | UMLSCUI |
| CHEBI:5693 | CHEBI |
| CHEMBL496 | ChEMBL_ID |
| D006582 | MESH_DESCRIPTOR_UI |
| DB00756 | DRUGBANK_ID |
| 3598 | PUBCHEM_CID |
| 11069 | IUPHAR_LIGAND_ID |
| 2033 | INN_ID |
| IWW5FV6NK2 | UNII |
| 5293 | RXNORM |
| 4826 | MMSL |
| 71944 | MMSL |
| 741 | MMSL |
| 003176 | NDDF |
| 1878008 | SNOMEDCT_US |
| 387103004 | SNOMEDCT_US |
None